Healthcare provider profile · identity verified

Ashok Kumar Bansal, MD

Internal Medicine · SOUTHFIELD, MI · NPI 1114908209

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	824	132
Amlodipine Besylate	Amlodipine Besylate	397	68
Eliquis	Apixaban	394	35
Levothyroxine Sodium	Levothyroxine Sodium	329	39
Metoprolol Tartrate	Metoprolol Tartrate	291	54
Lisinopril	Lisinopril	262	43
Hydralazine Hcl	Hydralazine Hcl	224	33
Gabapentin	Gabapentin	222	32
Tamsulosin Hcl	Tamsulosin Hcl	217	39
Levetiracetam	Levetiracetam	205	25
Furosemide	Furosemide	160	35
Mirtazapine	Mirtazapine	154	32
Metformin Hcl	Metformin Hcl	151	30
Pravastatin Sodium	Pravastatin Sodium	151	suppressed
Clopidogrel	Clopidogrel Bisulfate	142	20
Pantoprazole Sodium	Pantoprazole Sodium	141	19
Quetiapine Fumarate	Quetiapine Fumarate	135	19
Sertraline Hcl	Sertraline Hcl	133	22
Losartan Potassium	Losartan Potassium	123	26
Trazodone Hcl	Trazodone Hcl	119	23
Carvedilol	Carvedilol	117	26
Divalproex Sodium	Divalproex Sodium	117	23
Donepezil Hcl	Donepezil Hcl	104	19
Olanzapine	Olanzapine	104	17
Duloxetine Hcl	Duloxetine Hcl	79	suppressed
Famotidine	Famotidine	79	17
Enoxaparin Sodium	Enoxaparin Sodium	77	suppressed
Glipizide	Glipizide	73	suppressed
Humalog Kwikpen U-100	Insulin Lispro	73	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	26
Metoprolol Succinate	Metoprolol Succinate	73	14
Midodrine Hcl	Midodrine Hcl	73	15
Potassium Chloride	Potassium Chloride	73	16
Omeprazole	Omeprazole	67	24
Alprazolam	Alprazolam	65	17
Aripiprazole	Aripiprazole	65	suppressed
Ondansetron Hcl	Ondansetron Hcl	62	27
Lacosamide	Lacosamide	60	11
Memantine Hcl	Memantine Hcl	60	12
Sevelamer Carbonate	Sevelamer Carbonate	58	suppressed
Baclofen	Baclofen	55	suppressed
Benztropine Mesylate	Benztropine Mesylate	54	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	54	suppressed
Januvia	Sitagliptin Phosphate	50	suppressed
Risperidone	Risperidone	50	15
Escitalopram Oxalate	Escitalopram Oxalate	48	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	17
Oxycodone Hcl	Oxycodone Hcl	47	12
Gemtesa	Vibegron	46	suppressed
Ibuprofen	Ibuprofen	46	17
Latanoprost	Latanoprost	46	11
Nifedipine Er	Nifedipine	46	suppressed
Myrbetriq	Mirabegron	44	suppressed
Sevelamer Hcl	Sevelamer Hcl	44	suppressed
Enulose	Lactulose	40	16
Lyumjev Kwikpen U-100	Insulin Lispro-Aabc	40	suppressed
Albuterol Sulfate	Albuterol Sulfate	39	20
Breo Ellipta	Fluticasone/Vilanterol	39	suppressed
Haloperidol	Haloperidol	39	suppressed
Novolog Flexpen	Insulin Aspart	38	15
Linzess	Linaclotide	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	15
Hydrocortisone	Hydrocortisone	36	suppressed
Simvastatin	Simvastatin	36	suppressed
Glipizide Er	Glipizide	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	17
Buspirone Hcl	Buspirone Hcl	34	suppressed
Labetalol Hcl	Labetalol Hcl	34	suppressed
Tradjenta	Linagliptin	33	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Prednisone	Prednisone	32	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	14
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Lorazepam	Lorazepam	31	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Prednisolone Acetate	Prednisolone Acetate	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Novolog	Insulin Aspart	29	12
Valproic Acid	Valproic Acid (As Sodium Salt)	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Clonidine	Clonidine	28	suppressed
Finasteride	Finasteride	28	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Topiramate	Topiramate	26	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	25	suppressed
Methocarbamol	Methocarbamol	24	11
Fluticasone Propionate	Fluticasone Propionate	23	11
Lactulose	Lactulose	23	suppressed
Sodium Chloride	0.9 % Sodium Chloride	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	21	12
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	19	suppressed
Ivermectin	Ivermectin	19	13
Cephalexin	Cephalexin	18	14
Meloxicam	Meloxicam	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	11
Levemir Flexpen	Insulin Detemir	17	suppressed
Briviact	Brivaracetam	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	11
Doxepin Hcl	Doxepin Hcl	16	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Mupirocin	Mupirocin	16	suppressed
Phenytek	Phenytoin Sodium Extended	16	suppressed
Vancomycin Hcl	Vancomycin Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Glatopa	Glatiramer Acetate	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Insulin Aspart	Insulin Aspart	14	12
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Trintellix	Vortioxetine Hydrobromide	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Levemir	Insulin Detemir	13	suppressed
Rivastigmine	Rivastigmine	13	suppressed
Difluprednate	Difluprednate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Nystop	Nystatin	12	suppressed
Ofloxacin	Ofloxacin	12	suppressed
Phenytoin	Phenytoin	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Acetazolamide Er	Acetazolamide	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error